TP53 and cancer: The effect of wogonin on glycolysis was attenuated or even reversed in mutant p53 and p53-null cells both in vivo or in vitro, which further verified that the anti-glycolysis and anti-cancer effects were largely dependent on fully-functioning p53 [30].